9272 tests performed with 82185 sites detected as strongly adaptive and 707544 as nearly-neutral.
\scriptsize
\begin{longtable}{lrrrrr}
\toprule
                                     Gene Ontology & $n_{\mathrm{Observed}}$ & $n_{\mathrm{Expected}}$ & Odds ratio & $p_{\mathrm{value}}$ & $e_{\mathrm{value}}$ \\
\midrule
\endhead
\midrule
\multicolumn{6}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                  basal ectoplasmic specialization &                     739 &                    63.0 &       11.7 &                    0 &                    0 \\
                            innate immune response &                    4627 &                  1909.9 &      2.423 &                    0 &                    0 \\
                             immune system process &                    5426 &                  2206.7 &      2.459 &                    0 &                    0 \\
                         defense response to virus &                    1894 &                   715.7 &      2.646 &        6.2e$^{-247}$ &        5.7e$^{-243}$ \\
               regulation of complement activation &                    1281 &                   397.5 &      3.223 &        5.3e$^{-227}$ &        4.9e$^{-223}$ \\
 positive regulation of double-strand break rep... &                     502 &                    56.4 &      8.904 &        2.3e$^{-221}$ &        2.1e$^{-217}$ \\
 RNA polymerase III transcriptional preinitiati... &                     676 &                   126.1 &      5.360 &        1.5e$^{-208}$ &        1.4e$^{-204}$ \\
         TFIIIC-class transcription factor binding &                     676 &                   127.5 &      5.302 &        1.3e$^{-206}$ &        1.2e$^{-202}$ \\
                             complement activation &                    1023 &                   289.9 &      3.529 &        1.2e$^{-204}$ &        1.1e$^{-200}$ \\
         TFIIIB-type transcription factor activity &                     676 &                   134.4 &      5.029 &        2.8e$^{-197}$ &        2.6e$^{-193}$ \\
               transcription factor TFIIIB complex &                     676 &                   134.4 &      5.029 &        2.8e$^{-197}$ &        2.6e$^{-193}$ \\
              NAD+ ADP-ribosyltransferase activity &                     938 &                   255.8 &      3.666 &        8.7e$^{-197}$ &        8.1e$^{-193}$ \\
             ubiquitin-like protein ligase binding &                     502 &                    68.6 &      7.314 &          4e$^{-196}$ &        3.7e$^{-192}$ \\
          positive regulation of chromatin binding &                     506 &                    75.7 &      6.686 &        6.9e$^{-186}$ &        6.4e$^{-182}$ \\
                                 acrosomal vesicle &                    1273 &                   455.7 &      2.793 &          8e$^{-183}$ &        7.4e$^{-179}$ \\
 regulation of transcription from RNA polymeras... &                     949 &                   283.8 &      3.344 &        1.6e$^{-177}$ &        1.5e$^{-173}$ \\
                        double-strand break repair &                    1686 &                   727.3 &      2.318 &        1.8e$^{-172}$ &        1.6e$^{-168}$ \\
                          protein ADP-ribosylation &                     793 &                   211.2 &      3.755 &        1.5e$^{-171}$ &        1.4e$^{-167}$ \\
 positive regulation of tyrosine phosphorylatio... &                    1054 &                   354.7 &      2.971 &          5e$^{-167}$ &        4.7e$^{-163}$ \\
                                        DNA repair &                    4666 &                  2915.7 &      1.600 &          6e$^{-165}$ &        5.5e$^{-161}$ \\
                       STAT family protein binding &                     509 &                    91.5 &      5.561 &        1.6e$^{-162}$ &        1.5e$^{-158}$ \\
                  external side of plasma membrane &                    2237 &                  1135.4 &      1.970 &        7.8e$^{-157}$ &        7.2e$^{-153}$ \\
                               blood microparticle &                    1377 &                   581.8 &      2.367 &        1.8e$^{-147}$ &        1.7e$^{-143}$ \\
        regulation of response to interferon-gamma &                     296 &                    26.7 &       11.1 &        2.6e$^{-147}$ &        2.4e$^{-143}$ \\
                              ADP-D-ribose binding &                     296 &                    26.7 &       11.1 &        2.6e$^{-147}$ &        2.4e$^{-143}$ \\
 NAD biosynthesis via nicotinamide riboside sal... &                     334 &                    40.9 &      8.175 &        9.3e$^{-141}$ &        8.6e$^{-137}$ \\
                     regulation of immune response &                     976 &                   350.4 &      2.785 &        2.8e$^{-140}$ &        2.6e$^{-136}$ \\
                          adaptive immune response &                    1295 &                   552.4 &      2.344 &        2.5e$^{-136}$ &        2.3e$^{-132}$ \\
                                site of DNA damage &                     345 &                    51.0 &      6.759 &          2e$^{-128}$ &        1.9e$^{-124}$ \\
 positive regulation of defense response to vir... &                     773 &                   254.3 &      3.040 &        2.1e$^{-127}$ &        1.9e$^{-123}$ \\
 positive regulation of protein localization to... &                     528 &                   128.4 &      4.111 &        3.5e$^{-127}$ &        3.2e$^{-123}$ \\
                                   cilium movement &                    1413 &                   665.3 &      2.124 &        2.1e$^{-120}$ &        1.9e$^{-116}$ \\
          cellular response to DNA damage stimulus &                    5237 &                  3634.0 &      1.441 &          1e$^{-115}$ &        9.6e$^{-112}$ \\
 positive regulation of interleukin-4-mediated ... &                     356 &                    64.1 &      5.552 &        3.5e$^{-114}$ &        3.3e$^{-110}$ \\
                                   immune response &                    2221 &                  1259.8 &      1.763 &        1.1e$^{-113}$ &          1e$^{-109}$ \\
                                 receptor activity &                    2114 &                  1196.7 &      1.767 &        4.5e$^{-109}$ &        4.2e$^{-105}$ \\
 negative regulation of tyrosine phosphorylatio... &                     356 &                    67.9 &      5.240 &        8.5e$^{-109}$ &        7.9e$^{-105}$ \\
                               DNA damage response &                     908 &                   365.1 &      2.487 &        7.5e$^{-108}$ &        6.9e$^{-104}$ \\
                    natural killer cell activation &                     405 &                    90.6 &      4.470 &          9e$^{-107}$ &        8.4e$^{-103}$ \\
 positive regulation of interferon-gamma-mediat... &                     311 &                    52.0 &      5.982 &        4.5e$^{-106}$ &        4.2e$^{-102}$ \\
    transcription from RNA polymerase III promoter &                     755 &                   276.0 &      2.736 &        4.8e$^{-106}$ &        4.5e$^{-102}$ \\
 negative regulation of interferon-gamma-mediat... &                     365 &                    74.7 &      4.889 &        6.6e$^{-105}$ &        6.1e$^{-101}$ \\
                               leukocyte migration &                    1253 &                   597.2 &      2.098 &        3.6e$^{-104}$ &        3.3e$^{-100}$ \\
                               other organism cell &                     197 &                    19.0 &       10.4 &         1.6e$^{-95}$ &         1.4e$^{-91}$ \\
                        regulation of opsonization &                     197 &                    19.0 &       10.4 &         1.6e$^{-95}$ &         1.4e$^{-91}$ \\
      negative regulation of complement activation &                     197 &                    19.0 &       10.4 &         1.6e$^{-95}$ &         1.4e$^{-91}$ \\
 detection of chemical stimulus involved in sen... &                     407 &                   103.9 &      3.916 &         1.6e$^{-93}$ &         1.5e$^{-89}$ \\
                                 response to virus &                     965 &                   431.7 &      2.235 &         6.3e$^{-93}$ &         5.9e$^{-89}$ \\
 attachment of spindle microtubules to kinetoch... &                     256 &                    40.2 &      6.368 &         7.6e$^{-92}$ &           7e$^{-88}$ \\
          condensed nuclear chromosome kinetochore &                     256 &                    40.2 &      6.368 &         7.6e$^{-92}$ &           7e$^{-88}$ \\
                                    enzyme binding &                    2582 &                  1629.5 &      1.585 &         1.8e$^{-90}$ &         1.7e$^{-86}$ \\
                         enzyme inhibitor activity &                     537 &                   175.7 &      3.057 &         5.8e$^{-90}$ &         5.4e$^{-86}$ \\
                                        hemostasis &                    1112 &                   538.4 &      2.065 &         1.9e$^{-89}$ &         1.8e$^{-85}$ \\
   negative regulation of viral genome replication &                     551 &                   185.6 &      2.969 &         1.9e$^{-88}$ &         1.8e$^{-84}$ \\
                transcriptional repressor activity &                     297 &                    59.2 &      5.018 &         9.1e$^{-88}$ &         8.4e$^{-84}$ \\
                        dynein light chain binding &                    1246 &                   646.1 &      1.929 &         3.4e$^{-84}$ &         3.2e$^{-80}$ \\
                            apical plasma membrane &                    3439 &                  2355.1 &      1.460 &         2.7e$^{-83}$ &         2.5e$^{-79}$ \\
 regulation of double-strand break repair via h... &                     662 &                   259.4 &      2.552 &         4.8e$^{-83}$ &         4.5e$^{-79}$ \\
                    antimicrobial humoral response &                     331 &                    78.3 &      4.228 &         6.4e$^{-83}$ &         5.9e$^{-79}$ \\
                             complement activation &                     496 &                   166.0 &      2.988 &         1.4e$^{-80}$ &         1.3e$^{-76}$ \\
 positive regulation of interferon-gamma produc... &                     616 &                   235.9 &      2.612 &         1.5e$^{-80}$ &         1.3e$^{-76}$ \\
                               strand displacement &                    1121 &                   569.5 &      1.968 &         3.8e$^{-80}$ &         3.5e$^{-76}$ \\
                      condensed nuclear chromosome &                     291 &                    63.4 &      4.593 &         2.4e$^{-79}$ &         2.3e$^{-75}$ \\
                        histone monoubiquitination &                     209 &                    30.8 &      6.779 &         9.7e$^{-79}$ &           9e$^{-75}$ \\
                        histone H2B ubiquitination &                     209 &                    30.8 &      6.779 &         9.7e$^{-79}$ &           9e$^{-75}$ \\
 positive regulation of NAD+ ADP-ribosyltransfe... &                     206 &                    29.8 &      6.916 &         1.1e$^{-78}$ &         9.8e$^{-75}$ \\
 positive regulation of receptor catabolic process &                     206 &                    29.8 &      6.916 &         1.1e$^{-78}$ &         9.8e$^{-75}$ \\
                        histone H2A ubiquitination &                     206 &                    29.8 &      6.916 &         1.1e$^{-78}$ &         9.8e$^{-75}$ \\
                                    dynein complex &                    1200 &                   629.7 &      1.906 &         1.2e$^{-78}$ &         1.1e$^{-74}$ \\
                               extracellular space &                    8347 &                  6587.1 &      1.267 &         1.2e$^{-78}$ &         1.1e$^{-74}$ \\
                                meiotic cell cycle &                    1939 &                  1181.2 &      1.642 &         1.5e$^{-78}$ &         1.4e$^{-74}$ \\
 positive regulation of transforming growth fac... &                     185 &                    24.2 &      7.635 &         1.3e$^{-75}$ &         1.2e$^{-71}$ \\
                                chemokine activity &                     317 &                    78.8 &      4.025 &         1.6e$^{-75}$ &         1.5e$^{-71}$ \\
                    chordate embryonic development &                     793 &                   358.6 &      2.211 &         4.3e$^{-75}$ &           4e$^{-71}$ \\
                           centromeric DNA binding &                     273 &                    59.7 &      4.576 &         2.7e$^{-74}$ &         2.5e$^{-70}$ \\
               T-helper 17 cell lineage commitment &                     138 &                    11.0 &       12.5 &         9.7e$^{-74}$ &           9e$^{-70}$ \\
                           membrane attack complex &                     476 &                   164.8 &      2.889 &         1.1e$^{-73}$ &         1.1e$^{-69}$ \\
             CENP-A containing nucleosome assembly &                     629 &                   257.4 &      2.444 &         4.2e$^{-73}$ &         3.9e$^{-69}$ \\
          ATP-dependent microtubule motor activity &                    1066 &                   551.7 &      1.932 &         9.1e$^{-73}$ &         8.5e$^{-69}$ \\
              DNA synthesis involved in DNA repair &                    1128 &                   596.4 &      1.891 &         1.3e$^{-72}$ &         1.2e$^{-68}$ \\
           dynein light intermediate chain binding &                    1074 &                   565.3 &      1.900 &         4.2e$^{-70}$ &         3.9e$^{-66}$ \\
                                 DNA recombination &                    1564 &                   929.0 &      1.684 &         7.5e$^{-70}$ &           7e$^{-66}$ \\
                              kinetochore assembly &                     290 &                    71.7 &      4.044 &         1.3e$^{-69}$ &         1.2e$^{-65}$ \\
                                         cytolysis &                     477 &                   171.6 &      2.779 &         1.4e$^{-69}$ &         1.3e$^{-65}$ \\
                            platelet degranulation &                    1441 &                   847.6 &      1.700 &         9.7e$^{-67}$ &           9e$^{-63}$ \\
                                  inner dynein arm &                     536 &                   212.4 &      2.523 &         2.5e$^{-66}$ &         2.3e$^{-62}$ \\
                          DNA cytosine deamination &                     101 &                   4.757 &       21.2 &         5.3e$^{-66}$ &         4.9e$^{-62}$ \\
 negative regulation of single stranded viral R... &                     101 &                   4.757 &       21.2 &         5.3e$^{-66}$ &         4.9e$^{-62}$ \\
              negative regulation of viral process &                     101 &                   4.757 &       21.2 &         5.3e$^{-66}$ &         4.9e$^{-62}$ \\
                    integral component of membrane &                   24998 &              2.2e$^{4}$ &      1.148 &         1.3e$^{-65}$ &         1.2e$^{-61}$ \\
 regulation of transcription from RNA polymeras... &                     169 &                    24.7 &      6.843 &         1.9e$^{-64}$ &         1.8e$^{-60}$ \\
 fusion of sperm to egg plasma membrane involve... &                     306 &                    85.3 &      3.589 &           4e$^{-64}$ &         3.7e$^{-60}$ \\
                           virus receptor activity &                     759 &                   362.2 &      2.096 &         5.5e$^{-64}$ &         5.1e$^{-60}$ \\
                              microvillus membrane &                     462 &                   172.7 &      2.675 &         1.8e$^{-63}$ &         1.7e$^{-59}$ \\
            telomere maintenance via recombination &                     700 &                   325.7 &      2.149 &         1.3e$^{-62}$ &         1.2e$^{-58}$ \\
                                  response to UV-C &                     672 &                   307.4 &      2.186 &         1.8e$^{-62}$ &         1.7e$^{-58}$ \\
                             inflammatory response &                    2465 &                  1678.7 &      1.468 &         1.8e$^{-62}$ &         1.7e$^{-58}$ \\
                            platelet alpha granule &                     471 &                   180.0 &      2.617 &         2.5e$^{-62}$ &         2.3e$^{-58}$ \\
                            macromolecular complex &                    3572 &                  2603.2 &      1.372 &         3.8e$^{-62}$ &         3.5e$^{-58}$ \\
                                copper ion binding &                     724 &                   343.2 &      2.110 &         4.5e$^{-62}$ &         4.2e$^{-58}$ \\
                             complement activation &                     555 &                   232.9 &      2.383 &         8.6e$^{-62}$ &         7.9e$^{-58}$ \\
 negative regulation of transcription by compet... &                     169 &                    26.6 &      6.365 &         2.9e$^{-61}$ &         2.7e$^{-57}$ \\
 negative regulation of ubiquitin-protein trans... &                     210 &                    43.1 &      4.870 &         5.4e$^{-61}$ &           5e$^{-57}$ \\
                                      brush border &                    1084 &                   605.2 &      1.791 &         7.4e$^{-60}$ &         6.9e$^{-56}$ \\
                binding of sperm to zona pellucida &                     389 &                   136.3 &      2.854 &         1.6e$^{-59}$ &         1.5e$^{-55}$ \\
               type I interferon signaling pathway &                     444 &                   168.8 &      2.631 &         2.1e$^{-59}$ &           2e$^{-55}$ \\
       defense response to Gram-negative bacterium &                     541 &                   228.9 &      2.364 &         2.3e$^{-59}$ &         2.1e$^{-55}$ \\
                     male meiotic nuclear division &                     692 &                   328.3 &      2.108 &         2.7e$^{-59}$ &         2.5e$^{-55}$ \\
                 dynein intermediate chain binding &                    1076 &                   601.2 &      1.790 &         2.7e$^{-59}$ &         2.5e$^{-55}$ \\
                              single fertilization &                     744 &                   365.2 &      2.037 &         9.7e$^{-59}$ &           9e$^{-55}$ \\
            negative regulation of gene expression &                    1368 &                   824.1 &      1.660 &         1.5e$^{-58}$ &         1.4e$^{-54}$ \\
                                          synapsis &                    1011 &                   556.1 &      1.818 &         1.7e$^{-58}$ &         1.5e$^{-54}$ \\
                         inner dynein arm assembly &                     660 &                   308.7 &      2.138 &         1.7e$^{-58}$ &         1.6e$^{-54}$ \\
                               O-glycan processing &                     567 &                   248.4 &      2.282 &         5.4e$^{-58}$ &           5e$^{-54}$ \\
                             extracellular exosome &                   12333 &                1e$^{4}$ &      1.184 &         7.3e$^{-58}$ &         6.8e$^{-54}$ \\
      positive regulation of macrophage activation &                     281 &                    79.7 &      3.525 &         8.5e$^{-58}$ &         7.9e$^{-54}$ \\
  positive regulation of interleukin-10 production &                     422 &                   159.0 &      2.655 &           2e$^{-57}$ &         1.9e$^{-53}$ \\
        COPII-coated ER to Golgi transport vesicle &                     537 &                   230.6 &      2.328 &           3e$^{-57}$ &         2.8e$^{-53}$ \\
        polymeric immunoglobulin receptor activity &                     162 &                    26.6 &      6.100 &         5.2e$^{-57}$ &         4.9e$^{-53}$ \\
 immunoglobulin transcytosis in epithelial cell... &                     162 &                    26.6 &      6.100 &         5.2e$^{-57}$ &         4.9e$^{-53}$ \\
               axonemal central apparatus assembly &                     543 &                   235.0 &      2.310 &         5.4e$^{-57}$ &           5e$^{-53}$ \\
                                    cell periphery &                     325 &                   104.0 &      3.124 &         5.7e$^{-57}$ &         5.2e$^{-53}$ \\
 intrinsic apoptotic signaling pathway in respo... &                     871 &                   461.4 &      1.888 &         2.4e$^{-56}$ &         2.2e$^{-52}$ \\
 endoplasmic reticulum-Golgi intermediate compa... &                     634 &                   297.6 &      2.130 &         8.1e$^{-56}$ &         7.6e$^{-52}$ \\
                                   spermatogenesis &                    3381 &                  2489.1 &      1.358 &         1.2e$^{-55}$ &         1.1e$^{-51}$ \\
 regulation of cyclin-dependent protein serine/... &                     510 &                   218.4 &      2.335 &         8.6e$^{-55}$ &           8e$^{-51}$ \\
                                            cilium &                    3226 &                  2370.1 &      1.361 &         6.3e$^{-54}$ &         5.8e$^{-50}$ \\
          negative regulation of blood coagulation &                     285 &                    86.9 &      3.279 &         1.5e$^{-53}$ &         1.4e$^{-49}$ \\
                                        cell aging &                     685 &                   339.1 &      2.020 &         3.5e$^{-53}$ &         3.3e$^{-49}$ \\
   positive regulation of interleukin-1 production &                     192 &                    41.9 &      4.587 &         5.9e$^{-53}$ &         5.5e$^{-49}$ \\
                                hydrolase activity &                     101 &                   8.702 &       11.6 &         1.3e$^{-52}$ &         1.2e$^{-48}$ \\
                                   DNA replication &                     142 &                    22.0 &      6.444 &         3.2e$^{-52}$ &           3e$^{-48}$ \\
 single-stranded DNA-dependent ATP-dependent DN... &                     142 &                    22.0 &      6.444 &         3.2e$^{-52}$ &           3e$^{-48}$ \\
  regulation of DNA double-strand break processing &                     142 &                    22.0 &      6.444 &         3.2e$^{-52}$ &           3e$^{-48}$ \\
         ATP-dependent 5'-3' DNA helicase activity &                     142 &                    22.2 &      6.410 &           5e$^{-52}$ &         4.6e$^{-48}$ \\
                      platelet alpha granule lumen &                    1081 &                   631.7 &      1.711 &         8.1e$^{-52}$ &         7.5e$^{-48}$ \\
     positive regulation of histone H4 acetylation &                     169 &                    33.0 &      5.114 &         1.3e$^{-51}$ &         1.2e$^{-47}$ \\
                                   lateral element &                     908 &                   506.4 &      1.793 &         1.1e$^{-50}$ &         9.8e$^{-47}$ \\
            regulation of T cell apoptotic process &                     156 &                    28.4 &      5.490 &         1.1e$^{-50}$ &         1.1e$^{-46}$ \\
 positive regulation of vascular endothelial gr... &                     659 &                   328.0 &      2.009 &         1.3e$^{-50}$ &         1.2e$^{-46}$ \\
 positive regulation of cell-cell adhesion medi... &                     120 &                    15.7 &      7.662 &         8.7e$^{-50}$ &         8.1e$^{-46}$ \\
 negative regulation of intrinsic apoptotic sig... &                     181 &                    40.1 &      4.511 &           3e$^{-49}$ &         2.8e$^{-45}$ \\
       negative regulation of mast cell activation &                     158 &                    30.5 &      5.180 &         6.7e$^{-49}$ &         6.2e$^{-45}$ \\
                     leukocyte adhesive activation &                     123 &                    17.2 &      7.164 &         7.4e$^{-49}$ &         6.9e$^{-45}$ \\
 negative regulation of cellular response to hy... &                     123 &                    17.2 &      7.164 &         7.4e$^{-49}$ &         6.9e$^{-45}$ \\
                                retina homeostasis &                     452 &                   193.6 &      2.335 &         8.8e$^{-49}$ &         8.1e$^{-45}$ \\
               positive regulation of angiogenesis &                    1198 &                   734.7 &      1.631 &         1.9e$^{-48}$ &         1.7e$^{-44}$ \\
  positive regulation of interleukin-12 production &                     465 &                   203.2 &      2.288 &         3.4e$^{-48}$ &         3.2e$^{-44}$ \\
                         peptide catabolic process &                     318 &                   113.3 &      2.806 &         8.8e$^{-48}$ &         8.2e$^{-44}$ \\
 positive regulation of oligodendrocyte progeni... &                     329 &                   120.0 &      2.741 &         1.4e$^{-47}$ &         1.3e$^{-43}$ \\
          folic acid import across plasma membrane &                     329 &                   120.0 &      2.741 &         1.4e$^{-47}$ &         1.3e$^{-43}$ \\
 positive regulation of lysosomal protein catab... &                     329 &                   120.0 &      2.741 &         1.4e$^{-47}$ &         1.3e$^{-43}$ \\
                  steroid hormone receptor binding &                     329 &                   120.0 &      2.741 &         1.4e$^{-47}$ &         1.3e$^{-43}$ \\
                             extracellular vesicle &                     718 &                   378.7 &      1.896 &         2.2e$^{-47}$ &           2e$^{-43}$ \\
                        viral entry into host cell &                     767 &                   414.1 &      1.852 &         2.2e$^{-47}$ &           2e$^{-43}$ \\
                                        chromosome &                    3599 &                  2743.1 &      1.312 &         2.4e$^{-47}$ &         2.3e$^{-43}$ \\
 double-strand break repair via homologous reco... &                    1398 &                   896.8 &      1.559 &         2.5e$^{-47}$ &         2.3e$^{-43}$ \\
                             BRCA2-MAGE-D1 complex &                     473 &                   211.1 &      2.241 &         5.8e$^{-47}$ &         5.4e$^{-43}$ \\
 mitotic recombination-dependent replication fo... &                     473 &                   211.1 &      2.241 &         5.8e$^{-47}$ &         5.4e$^{-43}$ \\
             H4 histone acetyltransferase activity &                     473 &                   211.1 &      2.241 &         5.8e$^{-47}$ &         5.4e$^{-43}$ \\
  glycerophosphodiester phosphodiesterase activity &                     148 &                    28.1 &      5.273 &         1.3e$^{-46}$ &         1.2e$^{-42}$ \\
                       cytidine deaminase activity &                     104 &                    12.1 &      8.619 &         1.7e$^{-46}$ &         1.6e$^{-42}$ \\
                              cytidine deamination &                     104 &                    12.1 &      8.619 &         1.7e$^{-46}$ &         1.6e$^{-42}$ \\
                    neuron projection arborization &                     329 &                   122.7 &      2.681 &         5.9e$^{-46}$ &         5.5e$^{-42}$ \\
                                 blood coagulation &                    1383 &                   892.6 &      1.549 &         1.1e$^{-45}$ &         9.7e$^{-42}$ \\
             H3 histone acetyltransferase activity &                     473 &                   214.0 &      2.211 &         1.2e$^{-45}$ &         1.1e$^{-41}$ \\
 establishment of protein localization to telomere &                     473 &                   214.1 &      2.209 &         1.3e$^{-45}$ &         1.2e$^{-41}$ \\
                         enzyme activator activity &                     541 &                   259.9 &      2.082 &         1.5e$^{-45}$ &         1.4e$^{-41}$ \\
                       double-stranded RNA binding &                     546 &                   263.5 &      2.072 &         1.8e$^{-45}$ &         1.6e$^{-41}$ \\
                serine-type endopeptidase activity &                    1224 &                   768.3 &      1.593 &         2.1e$^{-45}$ &         1.9e$^{-41}$ \\
           cell surface receptor signaling pathway &                    2015 &                  1410.0 &      1.429 &         2.7e$^{-45}$ &         2.5e$^{-41}$ \\
  negative regulation of cellular response to heat &                     113 &                    15.7 &      7.215 &         3.1e$^{-45}$ &         2.9e$^{-41}$ \\
 positive regulation of granulocyte colony-stim... &                     113 &                    15.7 &      7.215 &         3.1e$^{-45}$ &         2.9e$^{-41}$ \\
                    extracellular exosome assembly &                     113 &                    15.7 &      7.215 &         3.1e$^{-45}$ &         2.9e$^{-41}$ \\
 metanephric glomerular mesangial cell differen... &                     113 &                    15.7 &      7.215 &         3.1e$^{-45}$ &         2.9e$^{-41}$ \\
                    mesangial cell-matrix adhesion &                     113 &                    15.7 &      7.215 &         3.1e$^{-45}$ &         2.9e$^{-41}$ \\
                   glomerular endothelium fenestra &                     113 &                    15.7 &      7.215 &         3.1e$^{-45}$ &         2.9e$^{-41}$ \\
                      interleukin-1 beta secretion &                     226 &                    66.4 &      3.402 &         6.9e$^{-45}$ &         6.4e$^{-41}$ \\
                            amyloid-beta clearance &                     235 &                    71.2 &      3.302 &         7.1e$^{-45}$ &         6.6e$^{-41}$ \\
                       replication fork protection &                     574 &                   284.5 &      2.018 &         8.6e$^{-45}$ &           8e$^{-41}$ \\
                                tissue homeostasis &                     486 &                   225.4 &      2.156 &           2e$^{-44}$ &         1.8e$^{-40}$ \\
          2'-5'-oligoadenylate synthetase activity &                     220 &                    64.0 &      3.438 &         2.6e$^{-44}$ &         2.4e$^{-40}$ \\
 negative regulation of interferon-gamma produc... &                     407 &                   174.2 &      2.336 &         3.4e$^{-44}$ &         3.2e$^{-40}$ \\
        positive regulation of chemokine secretion &                     313 &                   116.3 &      2.690 &         4.7e$^{-44}$ &         4.4e$^{-40}$ \\
                                  rRNA (adenine-N6 &                     111 &                    15.8 &      7.035 &         9.7e$^{-44}$ &           9e$^{-40}$ \\
 transcription initiation from mitochondrial pr... &                     111 &                    15.8 &      7.035 &         9.7e$^{-44}$ &           9e$^{-40}$ \\
                                    endosome lumen &                     358 &                   145.2 &      2.466 &         3.2e$^{-43}$ &           3e$^{-39}$ \\
 negative regulation of mammary gland epithelia... &                     473 &                   220.4 &      2.146 &         6.8e$^{-43}$ &         6.3e$^{-39}$ \\
                    response to lipopolysaccharide &                    1166 &                   737.4 &      1.581 &         3.9e$^{-42}$ &         3.6e$^{-38}$ \\
 stimulatory C-type lectin receptor signaling p... &                     471 &                   221.2 &      2.129 &         5.5e$^{-42}$ &         5.1e$^{-38}$ \\
    negative regulation of interleukin-2 secretion &                     114 &                    17.9 &      6.380 &         5.5e$^{-42}$ &         5.1e$^{-38}$ \\
                                  receptor binding &                    2231 &                  1617.0 &      1.380 &         2.4e$^{-41}$ &         2.2e$^{-37}$ \\
 positive regulation of glial cell-derived neur... &                     113 &                    18.0 &      6.284 &         3.5e$^{-41}$ &         3.3e$^{-37}$ \\
                             response to bacterium &                     243 &                    80.6 &      3.016 &         4.7e$^{-41}$ &         4.3e$^{-37}$ \\
 posttranscriptional regulation of gene expression &                     326 &                   129.4 &      2.519 &           5e$^{-41}$ &         4.7e$^{-37}$ \\
                      transition metal ion binding &                     402 &                   177.9 &      2.259 &         6.8e$^{-41}$ &         6.3e$^{-37}$ \\
                                   lipase activity &                     230 &                    73.9 &      3.114 &           1e$^{-40}$ &         9.4e$^{-37}$ \\
                           lipid metabolic process &                    3396 &                  2625.5 &      1.293 &         1.1e$^{-40}$ &           1e$^{-36}$ \\
 antimicrobial humoral immune response mediated... &                      91 &                    10.8 &      8.432 &         2.1e$^{-40}$ &           2e$^{-36}$ \\
 positive regulation of transcription from RNA ... &                     171 &                    44.0 &      3.890 &         3.8e$^{-40}$ &         3.5e$^{-36}$ \\
  nucleobase-containing compound metabolic process &                     477 &                   229.9 &      2.075 &         4.1e$^{-40}$ &         3.8e$^{-36}$ \\
                        lipopolysaccharide binding &                     368 &                   157.8 &      2.332 &         5.2e$^{-40}$ &         4.8e$^{-36}$ \\
                          neutrophil degranulation &                    2482 &                  1841.5 &      1.348 &         7.3e$^{-40}$ &         6.8e$^{-36}$ \\
                cellular response to interleukin-6 &                     215 &                    67.0 &      3.208 &           1e$^{-39}$ &         9.4e$^{-36}$ \\
 attachment of mitotic spindle microtubules to ... &                     279 &                   103.9 &      2.686 &         2.2e$^{-39}$ &           2e$^{-35}$ \\
       intestinal epithelial structure maintenance &                     138 &                    29.5 &      4.684 &         2.5e$^{-39}$ &         2.4e$^{-35}$ \\
                               detection of fungus &                     138 &                    29.5 &      4.684 &         2.5e$^{-39}$ &         2.4e$^{-35}$ \\
 positive regulation of nucleotide-binding olig... &                     138 &                    29.5 &      4.684 &         2.5e$^{-39}$ &         2.4e$^{-35}$ \\
 positive regulation of oxidative stress-induce... &                     138 &                    29.5 &      4.684 &         2.5e$^{-39}$ &         2.4e$^{-35}$ \\
 positive regulation of nucleotide-binding olig... &                     138 &                    29.5 &      4.684 &         2.5e$^{-39}$ &         2.4e$^{-35}$ \\
  negative regulation of interleukin-23 production &                     138 &                    29.5 &      4.684 &         2.5e$^{-39}$ &         2.4e$^{-35}$ \\
 cytokine production involved in inflammatory r... &                     158 &                    38.6 &      4.091 &           3e$^{-39}$ &         2.8e$^{-35}$ \\
                              extracellular region &                   11824 &                1e$^{4}$ &      1.150 &           3e$^{-39}$ &         2.8e$^{-35}$ \\
                            chromosome segregation &                     887 &                   533.5 &      1.663 &         5.1e$^{-39}$ &         4.7e$^{-35}$ \\
 positive regulation of MHC class II biosynthet... &                     147 &                    33.8 &      4.355 &         5.3e$^{-39}$ &         4.9e$^{-35}$ \\
                  innate immune response in mucosa &                     116 &                    20.5 &      5.649 &         5.3e$^{-39}$ &         4.9e$^{-35}$ \\
                                 rRNA modification &                     113 &                    19.5 &      5.797 &         8.4e$^{-39}$ &         7.7e$^{-35}$ \\
      positive regulation of inflammatory response &                     546 &                   281.7 &      1.938 &         1.1e$^{-38}$ &         9.9e$^{-35}$ \\
               retinyl-palmitate esterase activity &                     193 &                    56.7 &      3.404 &         1.3e$^{-38}$ &         1.2e$^{-34}$ \\
  B cell proliferation involved in immune response &                     154 &                    37.6 &      4.098 &         2.3e$^{-38}$ &         2.1e$^{-34}$ \\
                                genetic imprinting &                     135 &                    29.0 &      4.655 &         2.7e$^{-38}$ &         2.5e$^{-34}$ \\
                   mu-type opioid receptor binding &                     135 &                    29.0 &      4.655 &         2.7e$^{-38}$ &         2.5e$^{-34}$ \\
                beta-2 adrenergic receptor binding &                     135 &                    29.0 &      4.655 &         2.7e$^{-38}$ &         2.5e$^{-34}$ \\
                 post-embryonic body morphogenesis &                     135 &                    29.0 &      4.655 &         2.7e$^{-38}$ &         2.5e$^{-34}$ \\
           sensory perception of chemical stimulus &                     135 &                    29.0 &      4.655 &         2.7e$^{-38}$ &         2.5e$^{-34}$ \\
       regulation of parathyroid hormone secretion &                     135 &                    29.0 &      4.655 &         2.7e$^{-38}$ &         2.5e$^{-34}$ \\
 corticotropin-releasing hormone receptor 1 bin... &                     135 &                    29.0 &      4.655 &         2.7e$^{-38}$ &         2.5e$^{-34}$ \\
                                 chaperone binding &                     707 &                   400.5 &      1.765 &         3.7e$^{-38}$ &         3.4e$^{-34}$ \\
         negative regulation of catalytic activity &                     436 &                   207.0 &      2.106 &         4.3e$^{-38}$ &           4e$^{-34}$ \\
 positive regulation of NLRP3 inflammasome comp... &                     226 &                    75.4 &      2.999 &         5.2e$^{-38}$ &         4.8e$^{-34}$ \\
                   hair follicle placode formation &                     135 &                    29.2 &      4.618 &         5.2e$^{-38}$ &         4.8e$^{-34}$ \\
              toll-like receptor signaling pathway &                     531 &                   273.4 &      1.942 &         6.9e$^{-38}$ &         6.4e$^{-34}$ \\
                             lymphocyte chemotaxis &                     106 &                    17.4 &      6.090 &         7.1e$^{-38}$ &         6.6e$^{-34}$ \\
                                   sulfate binding &                     123 &                    24.2 &      5.073 &         8.5e$^{-38}$ &         7.9e$^{-34}$ \\
                       vitamin D metabolic process &                     558 &                   293.3 &      1.903 &         1.2e$^{-37}$ &         1.1e$^{-33}$ \\
                         phospholipase A2 activity &                     394 &                   179.9 &      2.190 &         1.2e$^{-37}$ &         1.2e$^{-33}$ \\
        maintenance of gastrointestinal epithelium &                     168 &                    45.1 &      3.724 &         1.3e$^{-37}$ &         1.2e$^{-33}$ \\
         cilium movement involved in cell motility &                     433 &                   206.4 &      2.098 &         1.7e$^{-37}$ &         1.6e$^{-33}$ \\
                       pericentric heterochromatin &                     271 &                   102.4 &      2.648 &           2e$^{-37}$ &         1.8e$^{-33}$ \\
                     Fc receptor signaling pathway &                     173 &                    47.9 &      3.612 &         2.3e$^{-37}$ &         2.1e$^{-33}$ \\
                                 helicase activity &                    1480 &                  1015.6 &      1.457 &         2.6e$^{-37}$ &         2.4e$^{-33}$ \\
         phosphatidylcholine acyl-chain remodeling &                     394 &                   180.7 &      2.180 &         2.8e$^{-37}$ &         2.6e$^{-33}$ \\
 positive regulation of protein localization to... &                     207 &                    66.0 &      3.137 &         3.4e$^{-37}$ &         3.1e$^{-33}$ \\
 positive regulation of natural killer cell med... &                     225 &                    76.1 &      2.958 &         3.9e$^{-37}$ &         3.7e$^{-33}$ \\
                   rRNA methyltransferase activity &                     138 &                    31.4 &      4.390 &         5.2e$^{-37}$ &         4.8e$^{-33}$ \\
               ATP-dependent DNA helicase activity &                     460 &                   227.0 &      2.026 &         1.1e$^{-36}$ &           1e$^{-32}$ \\
      ventricular compact myocardium morphogenesis &                     341 &                   147.5 &      2.312 &         1.4e$^{-36}$ &         1.3e$^{-32}$ \\
        hemolysis by symbiont of host erythrocytes &                     150 &                    37.5 &      4.004 &         1.6e$^{-36}$ &         1.5e$^{-32}$ \\
 positive regulation of myeloid dendritic cell ... &                      93 &                    13.6 &      6.850 &         2.8e$^{-36}$ &         2.6e$^{-32}$ \\
                            angiotensin maturation &                     207 &                    67.3 &      3.078 &           3e$^{-36}$ &         2.8e$^{-32}$ \\
 negative regulation of tumor necrosis factor p... &                     490 &                   249.9 &      1.961 &           6e$^{-36}$ &         5.5e$^{-32}$ \\
         positive regulation of hydrolase activity &                     220 &                    75.0 &      2.933 &         6.7e$^{-36}$ &         6.3e$^{-32}$ \\
 positive regulation of NF-kappaB import into n... &                     311 &                   129.9 &      2.394 &           8e$^{-36}$ &         7.4e$^{-32}$ \\
                 protein localization to nucleolus &                     353 &                   157.1 &      2.247 &         9.7e$^{-36}$ &           9e$^{-32}$ \\
                      D1 dopamine receptor binding &                     136 &                    31.9 &      4.263 &         1.8e$^{-35}$ &         1.7e$^{-31}$ \\
             phospholipase A2 activity consuming 1 &                     331 &                   143.8 &      2.301 &         2.8e$^{-35}$ &         2.6e$^{-31}$ \\
            phospholipase A2 activity (consuming 1 &                     331 &                   143.8 &      2.301 &         2.8e$^{-35}$ &         2.6e$^{-31}$ \\
               lipopolysaccharide receptor complex &                     138 &                    33.1 &      4.174 &         3.2e$^{-35}$ &           3e$^{-31}$ \\
                         guanyl nucleotide binding &                     143 &                    35.5 &      4.029 &         3.9e$^{-35}$ &         3.6e$^{-31}$ \\
 maintenance of epithelial cell apical/basal po... &                     156 &                    41.9 &      3.725 &         4.4e$^{-35}$ &         4.1e$^{-31}$ \\
                             macrophage activation &                     233 &                    83.9 &      2.776 &         6.1e$^{-35}$ &         5.7e$^{-31}$ \\
                           axonemal dynein complex &                     629 &                   353.8 &      1.778 &         6.4e$^{-35}$ &           6e$^{-31}$ \\
  positive regulation of interleukin-17 production &                     260 &                   100.6 &      2.584 &         1.4e$^{-34}$ &         1.3e$^{-30}$ \\
                               mitotic cytokinesis &                     602 &                   335.4 &      1.795 &         1.9e$^{-34}$ &         1.8e$^{-30}$ \\
                                          lysosome &                    2132 &                  1584.5 &      1.346 &         2.8e$^{-34}$ &         2.6e$^{-30}$ \\
              positive regulation of odontogenesis &                     114 &                    23.3 &      4.888 &         4.7e$^{-34}$ &         4.3e$^{-30}$ \\
 positive regulation of protein targeting to mi... &                     465 &                   237.7 &      1.956 &         4.9e$^{-34}$ &         4.5e$^{-30}$ \\
 regulation of type I interferon-mediated signa... &                     136 &                    33.3 &      4.085 &         5.5e$^{-34}$ &         5.1e$^{-30}$ \\
                                      fibrinolysis &                     392 &                   187.4 &      2.092 &         6.1e$^{-34}$ &         5.6e$^{-30}$ \\
                                  protease binding &                    1011 &                   653.3 &      1.548 &         6.9e$^{-34}$ &         6.4e$^{-30}$ \\
                    metalloaminopeptidase activity &                     313 &                   135.3 &      2.314 &         8.1e$^{-34}$ &         7.5e$^{-30}$ \\
 positive regulation of interferon-alpha produc... &                     222 &                    79.4 &      2.795 &         9.9e$^{-34}$ &         9.2e$^{-30}$ \\
                       beta-galactosidase activity &                     101 &                    18.2 &      5.544 &         1.1e$^{-33}$ &           1e$^{-29}$ \\
                         cellular defense response &                     347 &                   158.0 &      2.197 &         1.3e$^{-33}$ &         1.2e$^{-29}$ \\
      positive regulation of macrophage chemotaxis &                     188 &                    60.5 &      3.105 &         1.7e$^{-33}$ &         1.6e$^{-29}$ \\
                  CXCR3 chemokine receptor binding &                      89 &                    13.8 &      6.445 &         2.2e$^{-33}$ &           2e$^{-29}$ \\
                        membrane raft polarization &                     101 &                    18.5 &      5.474 &         2.3e$^{-33}$ &         2.2e$^{-29}$ \\
               nuclear pericentric heterochromatin &                     296 &                   125.4 &      2.360 &         2.6e$^{-33}$ &         2.5e$^{-29}$ \\
                inner cell mass cell proliferation &                     483 &                   252.6 &      1.912 &         2.8e$^{-33}$ &         2.6e$^{-29}$ \\
                           renal water homeostasis &                     158 &                    44.9 &      3.520 &         2.9e$^{-33}$ &         2.7e$^{-29}$ \\
                            plasminogen activation &                     278 &                   114.4 &      2.430 &         4.1e$^{-33}$ &         3.8e$^{-29}$ \\
                              transdifferentiation &                     113 &                    23.7 &      4.774 &         4.4e$^{-33}$ &         4.1e$^{-29}$ \\
               secondary heart field specification &                     335 &                   151.4 &      2.213 &         5.3e$^{-33}$ &         4.9e$^{-29}$ \\
 cellular response to oxidised low-density lipo... &                     154 &                    43.2 &      3.569 &         5.3e$^{-33}$ &         4.9e$^{-29}$ \\
 positive regulation of heterotypic cell-cell a... &                     242 &                    92.5 &      2.616 &         5.8e$^{-33}$ &         5.3e$^{-29}$ \\
                                 blood coagulation &                     128 &                    30.5 &      4.195 &         5.8e$^{-33}$ &         5.4e$^{-29}$ \\
                     defense response to bacterium &                    1041 &                   683.3 &      1.524 &         1.1e$^{-32}$ &           1e$^{-28}$ \\
                         vitamin metabolic process &                     337 &                   153.4 &      2.196 &         1.1e$^{-32}$ &         1.1e$^{-28}$ \\
                          inner acrosomal membrane &                     102 &                    19.5 &      5.232 &         1.8e$^{-32}$ &         1.7e$^{-28}$ \\
                             lipoprotein transport &                     668 &                   392.0 &      1.704 &           2e$^{-32}$ &         1.8e$^{-28}$ \\
                    pulmonary artery morphogenesis &                     387 &                   188.1 &      2.058 &         2.7e$^{-32}$ &         2.5e$^{-28}$ \\
                glomerular endothelium development &                     113 &                    24.4 &      4.638 &         3.1e$^{-32}$ &         2.9e$^{-28}$ \\
 sequestering of extracellular ligand from rece... &                      72 &                   8.589 &      8.383 &         3.3e$^{-32}$ &         3.1e$^{-28}$ \\
                                CSF1-CSF1R complex &                     170 &                    52.7 &      3.228 &         4.7e$^{-32}$ &         4.4e$^{-28}$ \\
 macrophage colony-stimulating factor signaling... &                     170 &                    52.7 &      3.228 &         4.7e$^{-32}$ &         4.4e$^{-28}$ \\
                outflow tract septum morphogenesis &                     333 &                   152.3 &      2.187 &         5.2e$^{-32}$ &         4.8e$^{-28}$ \\
              alpha DNA polymerase:primase complex &                     156 &                    45.4 &      3.439 &         5.6e$^{-32}$ &         5.2e$^{-28}$ \\
                                nuclear chromosome &                    1248 &                   856.6 &      1.457 &         8.6e$^{-32}$ &         7.9e$^{-28}$ \\
 positive regulation of interleukin-8 biosynthe... &                     144 &                    39.4 &      3.651 &         8.6e$^{-32}$ &           8e$^{-28}$ \\
 negative regulation of double-strand break rep... &                     279 &                   117.8 &      2.369 &           1e$^{-31}$ &         9.5e$^{-28}$ \\
                  axonemal central pair projection &                     342 &                   159.2 &      2.148 &         1.3e$^{-31}$ &         1.2e$^{-27}$ \\
                       response to gamma radiation &                     583 &                   331.1 &      1.761 &         1.3e$^{-31}$ &         1.2e$^{-27}$ \\
                  CCR10 chemokine receptor binding &                      65 &                   6.732 &      9.655 &         1.6e$^{-31}$ &         1.4e$^{-27}$ \\
                                cell proliferation &                    2611 &                  2023.0 &      1.291 &         1.7e$^{-31}$ &         1.6e$^{-27}$ \\
                  heterotrimeric G-protein complex &                     147 &                    41.3 &      3.559 &         1.7e$^{-31}$ &         1.6e$^{-27}$ \\
                         epithelial tube formation &                      80 &                    11.7 &      6.825 &         2.3e$^{-31}$ &         2.1e$^{-27}$ \\
               positive regulation of neurogenesis &                     385 &                   189.2 &      2.035 &         2.6e$^{-31}$ &         2.4e$^{-27}$ \\
 negative regulation of intracellular estrogen ... &                     355 &                   169.0 &      2.101 &         3.3e$^{-31}$ &         3.1e$^{-27}$ \\
                   detection of lipopolysaccharide &                     144 &                    40.1 &      3.588 &         3.7e$^{-31}$ &         3.4e$^{-27}$ \\
                                      drug binding &                     710 &                   429.2 &      1.654 &           4e$^{-31}$ &         3.7e$^{-27}$ \\
                              DNA duplex unwinding &                     473 &                   252.5 &      1.873 &         6.3e$^{-31}$ &         5.9e$^{-27}$ \\
                              condensed chromosome &                     795 &                   496.3 &      1.602 &         6.8e$^{-31}$ &         6.3e$^{-27}$ \\
 positive regulation of type I interferon-media... &                     164 &                    51.0 &      3.213 &         8.4e$^{-31}$ &         7.8e$^{-27}$ \\
                    bile acid biosynthetic process &                     275 &                   117.3 &      2.344 &         1.1e$^{-30}$ &           1e$^{-26}$ \\
                 killing by host of symbiont cells &                      58 &                   5.108 &       11.4 &         1.3e$^{-30}$ &         1.2e$^{-26}$ \\
 negative regulation of growth of symbiont on o... &                      58 &                   5.108 &       11.4 &         1.3e$^{-30}$ &         1.2e$^{-26}$ \\
                                 oocyte maturation &                     493 &                   268.3 &      1.838 &         1.6e$^{-30}$ &         1.5e$^{-26}$ \\
                                 endocytic vesicle &                     689 &                   416.0 &      1.656 &         2.1e$^{-30}$ &         1.9e$^{-26}$ \\
              induction of bacterial agglutination &                     188 &                    64.9 &      2.895 &         2.3e$^{-30}$ &         2.1e$^{-26}$ \\
                 T cell receptor signaling pathway &                     646 &                   383.2 &      1.686 &         2.4e$^{-30}$ &         2.2e$^{-26}$ \\
                                       hemopoiesis &                     885 &                   570.3 &      1.552 &           3e$^{-30}$ &         2.8e$^{-26}$ \\
 regulation of systemic arterial blood pressure... &                     141 &                    39.8 &      3.543 &         4.1e$^{-30}$ &         3.8e$^{-26}$ \\
            oxysterol 7-alpha-hydroxylase activity &                      89 &                    15.9 &      5.598 &         4.1e$^{-30}$ &         3.8e$^{-26}$ \\
           prostate gland epithelium morphogenesis &                      89 &                    15.9 &      5.598 &         4.1e$^{-30}$ &         3.8e$^{-26}$ \\
                                   DNA replication &                    1787 &                  1323.0 &      1.351 &         8.3e$^{-30}$ &         7.7e$^{-26}$ \\
                       single-stranded DNA binding &                     923 &                   603.2 &      1.530 &         9.3e$^{-30}$ &         8.7e$^{-26}$ \\
                     coronary artery morphogenesis &                     363 &                   178.1 &      2.038 &         9.5e$^{-30}$ &         8.8e$^{-26}$ \\
                                 MutLalpha complex &                     183 &                    63.1 &      2.900 &         1.1e$^{-29}$ &         9.9e$^{-26}$ \\
            positive regulation of strand invasion &                     183 &                    63.1 &      2.900 &         1.1e$^{-29}$ &         9.9e$^{-26}$ \\
                    3'-flap-structured DNA binding &                     183 &                    63.1 &      2.900 &         1.1e$^{-29}$ &         9.9e$^{-26}$ \\
                   T-helper 1 type immune response &                     140 &                    40.1 &      3.488 &         2.3e$^{-29}$ &         2.1e$^{-25}$ \\
                   response to parathyroid hormone &                     148 &                    44.4 &      3.331 &         2.9e$^{-29}$ &         2.7e$^{-25}$ \\
                         regulation of cytokinesis &                     698 &                   427.7 &      1.632 &           3e$^{-29}$ &         2.8e$^{-25}$ \\
            angiotensin catabolic process in blood &                      97 &                    19.8 &      4.888 &         3.1e$^{-29}$ &         2.9e$^{-25}$ \\
 intrinsic apoptotic signaling pathway in respo... &                     482 &                   264.5 &      1.822 &         3.3e$^{-29}$ &           3e$^{-25}$ \\
                           toxic substance binding &                     189 &                    67.4 &      2.805 &         3.8e$^{-29}$ &         3.6e$^{-25}$ \\
         positive regulation of mitotic cell cycle &                     496 &                   275.4 &      1.801 &         4.9e$^{-29}$ &         4.6e$^{-25}$ \\
                               trachea development &                     345 &                   167.6 &      2.058 &           5e$^{-29}$ &         4.6e$^{-25}$ \\
 negative regulation of mitochondrial RNA catab... &                     155 &                    48.5 &      3.197 &         5.2e$^{-29}$ &         4.8e$^{-25}$ \\
 negative regulation of hematopoietic stem cell... &                     148 &                    45.1 &      3.280 &         1.1e$^{-28}$ &         9.7e$^{-25}$ \\
            cellular response to lipoteichoic acid &                     202 &                    75.8 &      2.663 &         1.2e$^{-28}$ &         1.1e$^{-24}$ \\
                      condensed nuclear chromosome &                     772 &                   488.5 &      1.580 &         1.4e$^{-28}$ &         1.3e$^{-24}$ \\
              activation of innate immune response &                     269 &                   117.9 &      2.281 &         1.5e$^{-28}$ &         1.4e$^{-24}$ \\
 nitric oxide production involved in inflammato... &                     139 &                    40.6 &      3.423 &         1.6e$^{-28}$ &         1.5e$^{-24}$ \\
          positive regulation of acrosome reaction &                     200 &                    74.9 &      2.669 &         1.8e$^{-28}$ &         1.6e$^{-24}$ \\
                                      HULC complex &                      67 &                   8.822 &      7.595 &         2.2e$^{-28}$ &           2e$^{-24}$ \\
                      telomeric D-loop disassembly &                     402 &                   209.3 &      1.921 &         2.3e$^{-28}$ &         2.1e$^{-24}$ \\
 positive regulation of protein serine/threonin... &                     276 &                   122.9 &      2.246 &         2.4e$^{-28}$ &         2.2e$^{-24}$ \\
                        nucleotide-excision repair &                     814 &                   523.5 &      1.555 &         3.2e$^{-28}$ &           3e$^{-24}$ \\
                        axonemal central apparatus &                     201 &                    76.2 &      2.638 &         4.5e$^{-28}$ &         4.1e$^{-24}$ \\
             integral component of plasma membrane &                    7061 &                  6095.9 &      1.158 &         4.5e$^{-28}$ &         4.1e$^{-24}$ \\
                      regulation of blood pressure &                     528 &                   302.7 &      1.744 &         5.2e$^{-28}$ &         4.9e$^{-24}$ \\
                    antibacterial humoral response &                      72 &                    10.8 &      6.670 &         5.7e$^{-28}$ &         5.2e$^{-24}$ \\
            regulation of adaptive immune response &                      93 &                    19.1 &      4.857 &           6e$^{-28}$ &         5.6e$^{-24}$ \\
                      other organism cell membrane &                     130 &                    36.8 &      3.535 &           8e$^{-28}$ &         7.4e$^{-24}$ \\
  regulation of dendritic cell cytokine production &                     172 &                    59.6 &      2.885 &         8.3e$^{-28}$ &         7.7e$^{-24}$ \\
 negative regulation of MyD88-independent toll-... &                     172 &                    59.6 &      2.885 &         8.3e$^{-28}$ &         7.7e$^{-24}$ \\
    pattern recognition receptor signaling pathway &                     113 &                    28.4 &      3.975 &         9.4e$^{-28}$ &         8.7e$^{-24}$ \\
                                lysosomal membrane &                    1841 &                  1386.0 &      1.328 &         1.1e$^{-27}$ &           1e$^{-23}$ \\
                        olfactory receptor binding &                      97 &                    21.1 &      4.593 &         1.1e$^{-27}$ &         1.1e$^{-23}$ \\
 adenylate cyclase-activating adrenergic recept... &                     137 &                    40.7 &      3.364 &         1.5e$^{-27}$ &         1.4e$^{-23}$ \\
                               platelet activation &                     705 &                   440.7 &      1.600 &         1.7e$^{-27}$ &         1.6e$^{-23}$ \\
                                        chromosome &                    1582 &                  1166.4 &      1.356 &         2.6e$^{-27}$ &         2.4e$^{-23}$ \\
                  lipoprotein transporter activity &                     422 &                   226.9 &      1.860 &         2.7e$^{-27}$ &         2.5e$^{-23}$ \\
                           aminopeptidase activity &                     296 &                   139.0 &      2.129 &         4.1e$^{-27}$ &         3.8e$^{-23}$ \\
                            protein polymerization &                     169 &                    59.0 &      2.862 &         4.8e$^{-27}$ &         4.4e$^{-23}$ \\
                                 response to X-ray &                     559 &                   330.2 &      1.693 &         6.9e$^{-27}$ &         6.4e$^{-23}$ \\
     cellular response to prostaglandin E stimulus &                     165 &                    57.1 &      2.891 &         7.8e$^{-27}$ &         7.3e$^{-23}$ \\
 positive regulation of cytokine production inv... &                     249 &                   109.1 &      2.282 &         1.4e$^{-26}$ &         1.3e$^{-22}$ \\
 positive regulation of reactive oxygen species... &                     159 &                    54.1 &      2.941 &         1.5e$^{-26}$ &         1.4e$^{-22}$ \\
              regulation of chromatin organization &                     397 &                   211.6 &      1.876 &         2.2e$^{-26}$ &         2.1e$^{-22}$ \\
                 positive regulation of exocytosis &                     422 &                   229.8 &      1.836 &         2.3e$^{-26}$ &         2.1e$^{-22}$ \\
 positive regulation of hematopoietic stem cell... &                     197 &                    76.8 &      2.566 &         2.4e$^{-26}$ &         2.3e$^{-22}$ \\
 negative regulation of T-helper 1 type immune ... &                     132 &                    39.7 &      3.327 &           3e$^{-26}$ &         2.8e$^{-22}$ \\
       positive regulation of chemokine production &                     297 &                   141.9 &      2.093 &         3.4e$^{-26}$ &         3.1e$^{-22}$ \\
               regulation of ribonuclease activity &                     124 &                    35.6 &      3.481 &         3.7e$^{-26}$ &         3.5e$^{-22}$ \\
    complement receptor mediated signaling pathway &                      89 &                    18.9 &      4.705 &         4.4e$^{-26}$ &         4.1e$^{-22}$ \\
        complement component C3a receptor activity &                      89 &                    18.9 &      4.705 &         4.4e$^{-26}$ &         4.1e$^{-22}$ \\
                      complement receptor activity &                      89 &                    18.9 &      4.705 &         4.4e$^{-26}$ &         4.1e$^{-22}$ \\
   signaling pattern recognition receptor activity &                     145 &                    47.0 &      3.086 &           5e$^{-26}$ &         4.6e$^{-22}$ \\
      positive regulation of ERK1 and ERK2 cascade &                    1055 &                   731.2 &      1.443 &         5.2e$^{-26}$ &         4.8e$^{-22}$ \\
                       3'-5' DNA helicase activity &                     185 &                    70.2 &      2.636 &         5.8e$^{-26}$ &         5.4e$^{-22}$ \\
                                  defense response &                     505 &                   293.1 &      1.723 &         7.1e$^{-26}$ &         6.6e$^{-22}$ \\
 negative regulation of cell adhesion mediated ... &                     199 &                    79.0 &      2.519 &         8.6e$^{-26}$ &           8e$^{-22}$ \\
 positive regulation of epithelial cell prolife... &                      94 &                    21.5 &      4.378 &         1.1e$^{-25}$ &         9.8e$^{-22}$ \\
       positive regulation of B cell proliferation &                     514 &                   300.6 &      1.710 &         1.1e$^{-25}$ &           1e$^{-21}$ \\
                                  rRNA methylation &                     151 &                    50.9 &      2.965 &         1.3e$^{-25}$ &         1.2e$^{-21}$ \\
 positive regulation of memory T cell different... &                     205 &                    83.3 &      2.462 &         1.8e$^{-25}$ &         1.6e$^{-21}$ \\
                          female gonad development &                     520 &                   306.1 &      1.699 &         1.9e$^{-25}$ &         1.8e$^{-21}$ \\
                                   cell projection &                    6315 &                  5453.9 &      1.158 &         2.1e$^{-25}$ &           2e$^{-21}$ \\
 positive regulation of tumor necrosis factor b... &                     168 &                    61.0 &      2.753 &         2.2e$^{-25}$ &           2e$^{-21}$ \\
                               metal ion transport &                     427 &                   236.8 &      1.804 &         2.4e$^{-25}$ &         2.2e$^{-21}$ \\
 negative regulation of extrinsic apoptotic sig... &                     592 &                   362.3 &      1.634 &         3.3e$^{-25}$ &           3e$^{-21}$ \\
                                 swimming behavior &                      69 &                    11.4 &      6.066 &         3.6e$^{-25}$ &         3.3e$^{-21}$ \\
 positive regulation of chronic inflammatory re... &                      69 &                    11.4 &      6.066 &         3.6e$^{-25}$ &         3.3e$^{-21}$ \\
               kynurenic acid biosynthetic process &                      69 &                    11.4 &      6.066 &         3.6e$^{-25}$ &         3.3e$^{-21}$ \\
                               BRCA1-BARD1 complex &                     311 &                   154.2 &      2.017 &         3.7e$^{-25}$ &         3.4e$^{-21}$ \\
                                   BRCA1-A complex &                     311 &                   154.2 &      2.017 &         3.7e$^{-25}$ &         3.4e$^{-21}$ \\
 positive regulation of interferon-beta biosynt... &                     178 &                    67.5 &      2.637 &         4.7e$^{-25}$ &         4.4e$^{-21}$ \\
        positive regulation of platelet activation &                     181 &                    69.4 &      2.609 &           5e$^{-25}$ &         4.7e$^{-21}$ \\
                                acrosomal membrane &                     350 &                   182.0 &      1.923 &         5.1e$^{-25}$ &         4.7e$^{-21}$ \\
            cellular response to indole-3-methanol &                     263 &                   122.5 &      2.148 &         9.6e$^{-25}$ &         8.9e$^{-21}$ \\
  positive regulation of histone H3-K9 methylation &                     263 &                   122.5 &      2.148 &         9.6e$^{-25}$ &         8.9e$^{-21}$ \\
 positive regulation of histone H4-K20 methylation &                     263 &                   122.5 &      2.148 &         9.6e$^{-25}$ &         8.9e$^{-21}$ \\
  negative regulation of histone H3-K4 methylation &                     263 &                   122.5 &      2.148 &         9.6e$^{-25}$ &         8.9e$^{-21}$ \\
                mitotic G2/M transition checkpoint &                     263 &                   122.5 &      2.148 &         9.6e$^{-25}$ &         8.9e$^{-21}$ \\
  positive regulation of peptide hormone secretion &                     221 &                    95.0 &      2.327 &         1.1e$^{-24}$ &           1e$^{-20}$ \\
                    ventricular system development &                     358 &                   188.8 &      1.896 &         1.2e$^{-24}$ &         1.1e$^{-20}$ \\
  positive regulation of histone H3-K9 acetylation &                     303 &                   150.0 &      2.020 &         1.2e$^{-24}$ &         1.1e$^{-20}$ \\
                         regulation of growth rate &                     192 &                    76.8 &      2.500 &         1.2e$^{-24}$ &         1.2e$^{-20}$ \\
                                vagina development &                     341 &                   177.2 &      1.924 &         1.9e$^{-24}$ &         1.8e$^{-20}$ \\
 anchored component of external side of plasma ... &                     326 &                   166.7 &      1.956 &           2e$^{-24}$ &         1.9e$^{-20}$ \\
                              plasma membrane raft &                     147 &                    50.5 &      2.913 &         2.3e$^{-24}$ &         2.2e$^{-20}$ \\
                 prostaglandin D receptor activity &                      46 &                   4.179 &       11.0 &           3e$^{-24}$ &         2.8e$^{-20}$ \\
                 prostaglandin J receptor activity &                      46 &                   4.179 &       11.0 &           3e$^{-24}$ &         2.8e$^{-20}$ \\
 negative regulation of male germ cell prolifer... &                      46 &                   4.179 &       11.0 &           3e$^{-24}$ &         2.8e$^{-20}$ \\
              lipopolysaccharide receptor activity &                     196 &                    80.0 &      2.449 &         3.2e$^{-24}$ &           3e$^{-20}$ \\
                            histone H4 acetylation &                     480 &                   280.4 &      1.712 &         3.4e$^{-24}$ &         3.1e$^{-20}$ \\
 negative regulation of granulocyte macrophage ... &                      79 &                    16.1 &      4.897 &         3.7e$^{-24}$ &         3.4e$^{-20}$ \\
 dosage compensation by inactivation of X chrom... &                     263 &                   123.8 &      2.124 &         3.7e$^{-24}$ &         3.4e$^{-20}$ \\
                            replicative cell aging &                     183 &                    72.3 &      2.532 &         4.6e$^{-24}$ &         4.2e$^{-20}$ \\
                        microtubule motor activity &                    1715 &                  1307.0 &      1.312 &         5.1e$^{-24}$ &         4.7e$^{-20}$ \\
              regulation of chromosome segregation &                     420 &                   236.1 &      1.779 &         5.1e$^{-24}$ &         4.7e$^{-20}$ \\
                                 blood coagulation &                     398 &                   220.1 &      1.808 &         6.2e$^{-24}$ &         5.7e$^{-20}$ \\
                                   histone binding &                    1003 &                   701.1 &      1.431 &         7.6e$^{-24}$ &           7e$^{-20}$ \\
                   cellular sodium ion homeostasis &                     142 &                    48.4 &      2.935 &         7.7e$^{-24}$ &         7.1e$^{-20}$ \\
  negative regulation of interleukin-18 production &                      88 &                    20.4 &      4.308 &         8.3e$^{-24}$ &         7.7e$^{-20}$ \\
                             astrocyte development &                     217 &                    94.5 &      2.296 &         1.2e$^{-23}$ &         1.1e$^{-19}$ \\
            positive regulation of immune response &                      85 &                    19.3 &      4.412 &         1.4e$^{-23}$ &         1.3e$^{-19}$ \\
      high-density lipoprotein particle remodeling &                     166 &                    62.9 &      2.640 &         1.6e$^{-23}$ &         1.4e$^{-19}$ \\
                             sperm-egg recognition &                     193 &                    79.7 &      2.422 &           2e$^{-23}$ &         1.9e$^{-19}$ \\
 positive regulation of osteoclast differentiation &                     344 &                   182.5 &      1.885 &         2.1e$^{-23}$ &         1.9e$^{-19}$ \\
                           other organism membrane &                      82 &                    18.1 &      4.529 &         2.4e$^{-23}$ &         2.2e$^{-19}$ \\
                                      cell killing &                      82 &                    18.1 &      4.529 &         2.4e$^{-23}$ &         2.2e$^{-19}$ \\
                                 blood coagulation &                     178 &                    70.5 &      2.524 &         2.5e$^{-23}$ &         2.3e$^{-19}$ \\
                               clathrin-coated pit &                     687 &                   446.0 &      1.540 &         2.9e$^{-23}$ &         2.7e$^{-19}$ \\
                  negative regulation of cytolysis &                      47 &                   4.876 &      9.639 &         3.2e$^{-23}$ &           3e$^{-19}$ \\
                        epithelial fluid transport &                      47 &                   4.876 &      9.639 &         3.2e$^{-23}$ &           3e$^{-19}$ \\
                               histamine secretion &                      47 &                   4.876 &      9.639 &         3.2e$^{-23}$ &           3e$^{-19}$ \\
                       response to silicon dioxide &                      47 &                   4.876 &      9.639 &         3.2e$^{-23}$ &           3e$^{-19}$ \\
 granulocyte macrophage colony-stimulating fact... &                      47 &                   4.876 &      9.639 &         3.2e$^{-23}$ &           3e$^{-19}$ \\
                  clathrin-coated vesicle membrane &                     636 &                   405.8 &      1.567 &         3.5e$^{-23}$ &         3.2e$^{-19}$ \\
                                     motile cilium &                     796 &                   534.6 &      1.489 &         3.7e$^{-23}$ &         3.4e$^{-19}$ \\
 positive regulation of interferon-beta production &                     310 &                   159.0 &      1.950 &         3.7e$^{-23}$ &         3.5e$^{-19}$ \\
 positive regulation of macrophage derived foam... &                     244 &                   113.7 &      2.147 &         4.6e$^{-23}$ &         4.2e$^{-19}$ \\
  negative regulation of interleukin-17 production &                     206 &                    88.7 &      2.322 &           5e$^{-23}$ &         4.6e$^{-19}$ \\
 negative regulation of nitric oxide biosynthet... &                     164 &                    62.6 &      2.618 &         5.8e$^{-23}$ &         5.4e$^{-19}$ \\
                         ISG15-protein conjugation &                     113 &                    33.8 &      3.346 &         6.9e$^{-23}$ &         6.4e$^{-19}$ \\
                  ISG15 activating enzyme activity &                     113 &                    33.8 &      3.346 &         6.9e$^{-23}$ &         6.4e$^{-19}$ \\
 xenobiotic transmembrane transporting ATPase a... &                     220 &                    98.2 &      2.239 &         7.7e$^{-23}$ &         7.1e$^{-19}$ \\
                          DNA translocase activity &                     142 &                    49.9 &      2.846 &           8e$^{-23}$ &         7.4e$^{-19}$ \\
          positive regulation of protein secretion &                     468 &                   276.5 &      1.693 &           8e$^{-23}$ &         7.4e$^{-19}$ \\
 positive regulation of interferon-gamma secretion &                     152 &                    55.8 &      2.724 &           9e$^{-23}$ &         8.4e$^{-19}$ \\
       insulin-like growth factor receptor binding &                     159 &                    60.0 &      2.651 &         9.2e$^{-23}$ &         8.5e$^{-19}$ \\
                                t-circle formation &                     495 &                   297.9 &      1.662 &         1.2e$^{-22}$ &         1.2e$^{-18}$ \\
                                        chromosome &                     923 &                   642.2 &      1.437 &         1.4e$^{-22}$ &         1.3e$^{-18}$ \\
                             sperm principal piece &                     261 &                   126.4 &      2.065 &         1.4e$^{-22}$ &         1.3e$^{-18}$ \\
          cellular response to mechanical stimulus &                     521 &                   318.4 &      1.636 &         1.6e$^{-22}$ &         1.5e$^{-18}$ \\
                                 blood circulation &                     437 &                   254.2 &      1.719 &         1.7e$^{-22}$ &         1.5e$^{-18}$ \\
                                 B cell chemotaxis &                     131 &                    44.1 &      2.971 &         1.7e$^{-22}$ &         1.5e$^{-18}$ \\
                                   cell chemotaxis &                     323 &                   170.2 &      1.898 &         1.8e$^{-22}$ &         1.7e$^{-18}$ \\
        negative regulation of histone acetylation &                     278 &                   138.6 &      2.006 &         2.1e$^{-22}$ &         1.9e$^{-18}$ \\
                                       RNA binding &                    6994 &                  6140.8 &      1.139 &         2.4e$^{-22}$ &         2.3e$^{-18}$ \\
            toll-like receptor 4 signaling pathway &                     159 &                    60.8 &      2.615 &         2.8e$^{-22}$ &         2.6e$^{-18}$ \\
                                 T cell chemotaxis &                     121 &                    38.9 &      3.113 &         2.9e$^{-22}$ &         2.7e$^{-18}$ \\
                             gamma-tubulin binding &                     691 &                   454.4 &      1.521 &         3.2e$^{-22}$ &         2.9e$^{-18}$ \\
                           azurophil granule lumen &                     321 &                   169.5 &      1.894 &         3.2e$^{-22}$ &           3e$^{-18}$ \\
    positive regulation of MDA-5 signaling pathway &                     170 &                    67.6 &      2.514 &         3.3e$^{-22}$ &         3.1e$^{-18}$ \\
                       centromere complex assembly &                     109 &                    32.5 &      3.355 &         3.3e$^{-22}$ &         3.1e$^{-18}$ \\
 positive regulation of interleukin-12 biosynth... &                     142 &                    51.2 &      2.775 &         5.4e$^{-22}$ &           5e$^{-18}$ \\
 neutrophil mediated killing of gram-positive b... &                      53 &                   7.430 &      7.133 &         6.1e$^{-22}$ &         5.7e$^{-18}$ \\
                        azurophil granule membrane &                     762 &                   513.6 &      1.484 &         6.5e$^{-22}$ &           6e$^{-18}$ \\
       positive regulation of T cell proliferation &                     408 &                   234.6 &      1.739 &           7e$^{-22}$ &         6.5e$^{-18}$ \\
                  regulation of cytokine secretion &                     224 &                   103.1 &      2.172 &         7.5e$^{-22}$ &           7e$^{-18}$ \\
                                            uropod &                     138 &                    49.1 &      2.812 &         7.7e$^{-22}$ &         7.1e$^{-18}$ \\
                              platelet aggregation &                     396 &                   226.3 &      1.750 &         1.1e$^{-21}$ &           1e$^{-17}$ \\
           regulation of mitochondrial translation &                     150 &                    56.4 &      2.660 &         1.1e$^{-21}$ &           1e$^{-17}$ \\
 negative regulation of growth of symbiont in host &                     147 &                    54.6 &      2.690 &         1.2e$^{-21}$ &         1.1e$^{-17}$ \\
                                    nuclear matrix &                     866 &                   600.6 &      1.442 &         1.2e$^{-21}$ &         1.1e$^{-17}$ \\
                            collagen type I trimer &                      65 &                    12.2 &      5.333 &         1.3e$^{-21}$ &         1.2e$^{-17}$ \\
      G-protein beta/gamma-subunit complex binding &                     157 &                    60.9 &      2.578 &         1.6e$^{-21}$ &         1.5e$^{-17}$ \\
    positive regulation of RIG-I signaling pathway &                     170 &                    69.0 &      2.463 &         1.9e$^{-21}$ &         1.7e$^{-17}$ \\
                  protein K6-linked ubiquitination &                     319 &                   170.8 &      1.868 &         2.5e$^{-21}$ &         2.4e$^{-17}$ \\
                       regulation of TOR signaling &                     333 &                   181.0 &      1.840 &         2.6e$^{-21}$ &         2.4e$^{-17}$ \\
                    endosome to lysosome transport &                     221 &                   102.4 &      2.158 &         2.8e$^{-21}$ &         2.6e$^{-17}$ \\
 positive regulation of macrophage cytokine pro... &                     165 &                    66.2 &      2.491 &         2.8e$^{-21}$ &         2.6e$^{-17}$ \\
                                 secretory granule &                     832 &                   575.3 &      1.446 &         3.5e$^{-21}$ &         3.3e$^{-17}$ \\
            RNA-dependent DNA biosynthetic process &                     198 &                    87.6 &      2.261 &           4e$^{-21}$ &         3.8e$^{-17}$ \\
                               telomerase activity &                     198 &                    87.6 &      2.261 &           4e$^{-21}$ &         3.8e$^{-17}$ \\
                   interleukin-1 receptor activity &                     147 &                    55.7 &      2.639 &         4.9e$^{-21}$ &         4.6e$^{-17}$ \\
       cellular response to catecholamine stimulus &                     136 &                    49.2 &      2.764 &         5.1e$^{-21}$ &         4.7e$^{-17}$ \\
                              spindle organization &                     280 &                   143.9 &      1.946 &         5.7e$^{-21}$ &         5.3e$^{-17}$ \\
 positive regulation of glucose import in respo... &                     158 &                    62.5 &      2.527 &         6.1e$^{-21}$ &         5.6e$^{-17}$ \\
                                       GTP binding &                     994 &                   712.7 &      1.395 &         7.8e$^{-21}$ &         7.3e$^{-17}$ \\
             CD95 death-inducing signaling complex &                     118 &                    39.2 &      3.008 &         8.6e$^{-21}$ &         7.9e$^{-17}$ \\
                           stem cell proliferation &                     132 &                    47.2 &      2.795 &         8.7e$^{-21}$ &         8.1e$^{-17}$ \\
    positive regulation of interleukin-8 secretion &                     146 &                    55.8 &      2.616 &         1.3e$^{-20}$ &         1.2e$^{-16}$ \\
                                  female pregnancy &                     487 &                   300.0 &      1.623 &         1.3e$^{-20}$ &         1.2e$^{-16}$ \\
                DNA double-strand break processing &                     378 &                   216.7 &      1.745 &         1.3e$^{-20}$ &         1.2e$^{-16}$ \\
                              antioxidant activity &                     135 &                    49.3 &      2.738 &         1.4e$^{-20}$ &         1.3e$^{-16}$ \\
\end{longtable}
